CAJ | 학술논문

食管胃交界处腺癌（adenocarcinoma of esophagogastric junction，EGJA）有其独特的解剖学位置，同时又位于鳞状上皮与柱状上皮交界之处，其生物学特性不同于食管癌和胃癌，诊断分型一直存在众多的争议，治疗模式在学术界也始终没有公认的“金标准”，特别是局部进展期EGJA的治疗策略更是难以抉择。随着影像学技术的发展和各项大型临床研究结果的公布，EGJA的治疗日益个体化，同时也凸显了多学科协作的重要性。本文将针对以上问题对EGJA的最近进展做一综述。
식관위교계처선암（adenocarcinoma of esophagogastric junction，EGJA）유기독특적해부학위치，동시우위우린상상피여주상상피교계지처，기생물학특성불동우식관암화위암，진단분형일직존재음다적쟁의，치료모식재학술계야시종몰유공인적“금표준”，특별시국부진전기EGJA적치료책략경시난이결택。수착영상학기술적발전화각항대형림상연구결과적공포，EGJA적치료일익개체화，동시야철현료다학과협작적중요성。본문장침대이상문제대EGJA적최근진전주일종술。
The adenocarcinoma of the esophagogastric junction (EGJA) is located in a unique anatomical position and at the junction of the squamous epithelium and the columnar epithelium. The biological characteristics of this disease are different from those of esophageal or gastric cancer. The diagnostic classification of EGJA has been subject to controversies, and no gold standard therapeu-tic regimens have been established, especially in the choice of treatment of locally advanced EGJA. Results from large-scale clinical tri-als and imaging technology development showed that the treatment of EGJA has been individualized. Furthermore, this problem high-lights the importance of multidisciplinary collaboration. This article focuses on current progress in studies on EGJA.